CD28 and neoplasm: Finally, because programmed cell death protein 1 (PD-1) is known to inhibit CD28 signaling (12, 13), we combined XmAb808 with an anti–PD-1 antibody to increase its antitumor efficacy against human tumor xenografts in mice.